Scynexis (SCYX) FCF Margin (2013 - 2026)
Scynexis' (SCYX) quarterly FCF Margin came in at 98.69% in Q4 2025, up 111271.0% YoY from N/an in Q4 2024, and up 103.78% on a QoQ basis from 2611.98% in Q3 2025.
Scynexis (SCYX) FCF Margin (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 12 years of FCF Margin data on file, last reported at 98.69% in Q4 2025.
- Quarterly FCF Margin rose 111271.0% year-over-year to 98.69% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 29.09% (up 101528.0% YoY) and the FY2025 annual result came in at 25.64%, up 61528.0% from the prior year.
- FCF Margin grew to 98.69% in Q4 2025, from 2611.98% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 705.22% in Q3 2023 to a low of 4194.64% in Q4 2021.
- A 5-year average of 1251.16% and a median of 1404.46% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin soared 269818 bps — and 2025, when it slumped 272789 bps.
- Tracing SCYX's FCF Margin over 5 years: stood at 4194.64% in 2021, then soared by 64 bps to 1496.46% in 2022, then soared by 91 bps to 133.43% in 2023, then sank by 660 bps to 1014.02% in 2024, then jumped by 110 bps to 98.69% in 2025.
- The last three FCF Margin figures came in at 98.69% (Q4 2025), 2611.98% (Q3 2025), and 549.49% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | -6,334.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,334.04% |
| Dec 31, 2025 | 98.69% |
| Sep 30, 2025 | -2,611.98% |
| Jun 30, 2025 | -549.49% |
| Mar 31, 2025 | -2,904.67% |
| Dec 31, 2024 | -1,014.02% |
| Sep 30, 2024 | 115.91% |
| Jun 30, 2024 | -1,475.54% |
| Mar 31, 2024 | -291.84% |
| Dec 31, 2023 | -133.43% |
| Sep 30, 2023 | 705.22% |
| Jun 30, 2023 | 56.60% |
| Mar 31, 2023 | -1,674.60% |
| Dec 31, 2022 | -1,496.46% |
| Sep 30, 2022 | -1,445.60% |
| Jun 30, 2022 | -1,404.46% |
| Mar 31, 2022 | -2,284.00% |
| Dec 31, 2021 | -4,194.64% |
| Sep 30, 2021 | -3,259.88% |
| Mar 31, 2021 | -7.78% |